Shlomo Yanai - Articles and news items

Dr. Jeremy Levin

Teva announces management succession

Industry news, News / 1 January 2012 / Teva

Dr. Jeremy Levin, a former Senior Executive at Bristol-Myers Squibb, to succeed Shlomo Yanai as President and CEO…


Teva to acquire Cephalon in $6.8 billion transaction

Industry news, News / 2 May 2011 / Cephalon, Inc.

Teva will acquire all of the outstanding shares of Cephalon for a total enterprise value of approximately $6.8 billion…


The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...